Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spesolimab, an anti‐interleukin‐36 receptor antibody, in patients with moderate‐to‐severe atopic dermatitis: Results from a multicentre, randomized, double‐blind, placebo‐controlled, phase IIa study
Robert Bissonnette, William Abramovits, Étienne Saint‐Cyr Proulx, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 3, pp. 549-557
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 2
Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
Karolina Makowska, Joanna Nowaczyk, Leszek Blicharz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 781-781
Open Access | Times Cited: 35
Targeting IL-36 in Inflammatory Skin Diseases
Ryo Fukaura, Masashi Akiyama
BioDrugs (2023) Vol. 37, Iss. 3, pp. 279-293
Closed Access | Times Cited: 29
Challenges and Future Trends in Atopic Dermatitis
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 28
Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases
Fareed Ahmad, Majid Alam, Abdul W. Ansari, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 2, pp. 206-224
Closed Access | Times Cited: 14
Systemic Immunomodulatory Treatments for Atopic Dermatitis
Aaron M. Drucker, Megan Lam, David Prieto‐Merino, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 9, pp. 936-936
Closed Access | Times Cited: 13
Staphylococcus aureus proteases trigger eosinophil-mediated skin inflammation
Sabrina N. Kline, Nicholas Orlando, Alex J. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 6
Open Access | Times Cited: 7
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report
Pengfei Wen, Chuan Liu, Tingting Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access
Just scratching the surface: A review of pediatric skin allergies
Mary Grace Baker, Lara S. Ford, Dianne E. Campbell, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 2
Closed Access
Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases
Hanlin Zhang, Jia Zhou, Keyun Tang, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1303-1303
Open Access | Times Cited: 12
Rapid and sustained response to spesolimab in five Chinese patients with generalized pustular psoriasis
Delin Ran, Baoqi Yang, Lulu Sun, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 7, pp. 803-805
Closed Access | Times Cited: 11
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions
Kenneth B. Gordon, Yayoi Tada, Milan J. Anadkat, et al.
Dermatology and Therapy (2025)
Open Access
Emerging Systemic Treatment Options in Atopic Dermatitis
Andaç Salman, Ana M. Giménez‐Arnau
Balkan Medical Journal (2024), pp. 239-247
Open Access | Times Cited: 3
Spesolimab, the first‐in‐class anti‐IL‐36R antibody: From bench to clinic
Akimichi Morita, Yukari Okubo, Shinichi Imafuku, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 11, pp. 1379-1391
Open Access | Times Cited: 3
Interleukin antagonists for atopic dermatitis: a new era of therapy
Aikaterini Tsiogka, Eleni Paschou, Dimitra Koumaki, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 549-559
Closed Access | Times Cited: 2
Casting NETs on Psoriasis: The modulation of inflammatory feedback targeting IL-36/IL-36R axis
Zhihong Zhang, Zi‐Ying Zhan, Min Jiang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113190-113190
Closed Access | Times Cited: 2
Atopic dermatitis: pathogenesis and therapeutic intervention
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Cutaneous findings and treatments in deficiency of interleukin‐36 receptor antagonist (DITRA): A review of the literature
Chiamaka L. Okorie, Krithika Nayudu, Vinod E. Nambudiri
Experimental Dermatology (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 5
Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis
Reo Komaki, Tomomitsu Miyagaki, Miho Tanaka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11104-11104
Open Access | Times Cited: 4
Spesolimab: a comprehensive review on the anti‐IL‐36 receptor antibody in dermatology
Vijayasankar Palaniappan, Hima Gopinath, Aravind Baskar Murthy, et al.
International Journal of Dermatology (2023) Vol. 63, Iss. 1, pp. 88-93
Closed Access | Times Cited: 4
The Efficacy and Effectiveness of the Biological Treatment of Pruritus in the Course of Atopic Dermatitis
Agnieszka Hołdrowicz, Anna Woźniacka
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1754-1754
Open Access | Times Cited: 1
In Silico and In Vitro Analysis of IL36RN Alterations Reveals Critical Residues for the Function of the Interleukin-36 Receptor Complex
Karoliina Hassi, Timir Weston, Giulia Rinaldi, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 12, pp. 2468-2475.e6
Open Access | Times Cited: 3
A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials?
Jonathan I. Silverberg, Selwyn Ho, Raúl Collazo
Dermatology and Therapy (2023) Vol. 13, Iss. 12, pp. 3019-3029
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top